Role of ursolic acid chalcone, a synthetic analogue of ursolic acid, in inhibiting the properties of CD133(+) sphere-forming cells in liver stem cells.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Clinical and Experimental Pathology

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 25973027PMCID PMC4396281
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma.

  2012influential reference
• Human hepatocellular carcinomas with “Stemness”‐related marker expression: keratin 19 expression and a poor prognosis

  2011cited by this paper
• miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

  2010cited by this paper
• A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy.

  2010cited by this paper
• Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.

  2009cited by this paper
• Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

  2009cited by this paper
• ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma

  2009cited by this paper
• Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.

  2009cited by this paper
• EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.

  2009cited by this paper
• The Increasing Complexity of the Cancer Stem Cell Paradigm

  2009cited by this paper
• Molecular Cancer BioMed Central

  2008cited by this paper
• Exploring the role of cancer stem cells in radioresistance

  2008cited by this paper
• Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

  2008cited by this paper
• Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.

  2008cited by this paper
• Cancer stem cells in radiation resistance.

  2007cited by this paper
• A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

  2007cited by this paper
• Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

  2007cited by this paper
• CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

  2007cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• Chemotherapy resistance of glioblastoma stem cells

  2006cited by this paper
• Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties

  2006cited by this paper
• CD133+ renal progenitor cells contribute to tumor angiogenesis.

  2006cited by this paper
• Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells.

  2006cited by this paper
• Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies

  2005cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005cited by this paper
• CD133, a novel marker for human prostatic epithelial stem cells

  2004cited by this paper
• Characterization of cell types during rat liver development

  2003cited by this paper
• Pharmacology of oleanolic acid and ursolic acid

  2003cited by this paper
• Identification of a cancer stem cell in human brain tumors.

  2003cited by this paper
• Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

  2002cited by this paper
• Global cancer statistics in the year 2000.

  2001cited by this paper
• Activation of caspase-3 protease during the process of ursolic acid and its derivative-induced apoptosis.

  2001cited by this paper
• Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells.

  2000cited by this paper
• The Human AC133 Hematopoietic Stem Cell Antigen Is also Expressed in Epithelial Cells and Targeted to Plasma Membrane Protrusions*

  2000cited by this paper
• Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells.

  2000cited by this paper
• Direct isolation of human central nervous system stem cells.

  2000cited by this paper
• Cyclic adenosine monophosphate inhibits ursolic acid-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells.

  2000cited by this paper
• Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication

  2000cited by this paper
• Cytostatic, cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cells.

  2000cited by this paper
• Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis.

  1998cited by this paper
• Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages.

  1998cited by this paper
• Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells

  1998cited by this paper
• AC133, a novel marker for human hematopoietic stem and progenitor cells.

  1997cited by this paper
• Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest.

  1996cited by this paper
• Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.

  1996cited by this paper
• MCF-7 cell cycle arrested at G1 through ursolic acid, and increased reduction of tetrazolium salts.

  1996cited by this paper
• Pharmacology of oleanolic acid and ursolic acid.

  1995cited by this paper
• Anti-angiogenic activity of triterpene acids.

  1995cited by this paper
• Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.

  1994cited by this paper
• Inhibition of lipoxygenase activity and HL60 leukemic cell proliferation by ursolic acid isolated from heather flowers (Calluna vulgaris).

  1992cited by this paper
• Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells

  1992cited by this paper
• Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds.

  1988cited by this paper
• Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

  1986cited by this paper
• Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation; ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L.

  1986cited by this paper

• Inhibitory Effect and Mechanism of Ursolic Acid on Cisplatin-Induced Resistance and Stemness in Human Lung Cancer A549 Cells

  2023cites this paper
• Screening flavonoids and their synthetic analogs to target liver cancer stem-like cells

  2018cites this paper
• Terpenoids in Early 21st Century: From Renewable Functional Nano-entities to Advanced Materials

  2018cites this paper
• Ursolic acid (UA): A metabolite with promising therapeutic potential.

  2016cites this paper
• The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma

  2016cites this paper
• Preparation and Pre-clinical Evaluation of New Pentacyclic Triterpenoids

  2016cites this paper
• The plant-derived triterpenoid tingenin B is a potent anticancer agent due to its cytotoxic activity on cancer stem cells of breast cancer in vitro.

  2016cites this paper
• Anti-hepatocellular carcinoma activity and mechanism of chemopreventive compounds: ursolic acid derivatives

  2016cites this paper